MARKET PULSE-Prana, Nordion, UTi Worldwide, Novartis, Halozyme
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes opened higher on Monday, putting the S&P 500on track for a second straight advance, ahead of a speech by Federal Reserve Chair Janet Yellen. The Dow Jones industrial average was up 0.81 percent at 16,454.48, the S&P 500 was up 0.79 percent at 1,872.23 and the Nasdaq Composite was up 1.13 percent at 4,202.8.
** PRANA BIOTECHNOLOGY LTD, $2.94, -70.18 pct
The company said its experimental drug to treat Alzheimer's disease failed to meet the main goal of a mid-stage study in patients with a mild form of the condition.
** NORDION INC, $11.56, +11.05 pct
Sterigenics, a sterilization services provider owned by private equity firm GTCR LLC, has reached a deal to buy Canadian medical isotopes supplier Nordion for $727 million.
** UTI WORLDWIDE INC, $10.42, -7.46 pct Continued...